Medidata, a provider of cloud-based solutions and data analytics for clinical research has agreed to acquire Mytrus, Incorporated, an e-clinical technology company specializing in patient-centered electronic informed consent (eConsent) and virtual trials. Financial terms of the acquisition were not disclosed.
Medidata will integrate Enroll™, Mytrus’ eConsent solution, into the Medidata Clinical Cloud as part of its ongoing commitment to modernize clinical trials for patients, sites and sponsors. With widespread support from international regulatory agencies, recent FDA guidance documents, industry groups like Transcelerate and large central IRBs, the clinical research and bio banking industries are rapidly adopting eConsent as a preferred alternative to paper. The addition of Enroll to Medidata’s industry-leading cloud platform will allow Medidata to comprehensively address the industry’s conversion to this new technology.
Specific benefits include:
– Educating patients about the clinical trial experience through the use of multimedia and interactive content to create a more efficient consent process
– Informing site investigators’ understanding of patient questions, facilitating meaningful dialogue with the patient
– Helping sponsors increase patient retention and compliance, enabling better remote tracking of consent and improved document management and version control
“The informed consent process is one of the most important parts of running both ethical and effective research projects. It’s also the first step in giving patients a 21st Century experience, helping the critical elements of patient enrollment and retention in projects advancing healthcare,” said Medidata’s president, Glen de Vries. “Adding eConsent to the Medidata platform reinforces our commitment to improving patient engagement by delivering better tools, more data and higher quality insights for patients and researchers.”
